Tumour-infiltrating lymphocytes (TILs) as a predictor of response to neadjuvant chemotherapy in breast cancer

被引：0
|
作者：
Hernandez Leon, L. [1 ]
Tapia Melendo, G. [1 ]
Castello Fernandez, E. [1 ]
Sanhueza, T. V. [1 ]
Marginet Flinch, R. [1 ]
Martin Cespedes, M. [1 ]
Quiroga Garcia, V. [1 ]
Margeli Vila, M. [1 ]
机构：
[1] HUGTiP, Inst Catala Salut, Dept Pathol, Badalona, Spain
来源：
VIRCHOWS ARCHIV | 2018年 / 473卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-040
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer
    Kochi, Mariko
    Iwamoto, Takayuki
    Niikura, Naoki
    Bianchini, Giampaolo
    Masuda, Shinobu
    Mizoo, Taeko
    Nogami, Tomohiro
    Shien, Tadahiko
    Motoki, Takayuki
    Taira, Naruto
    Tokuda, Yutaka
    Doihara, Hiroyoshi
    Matsuoka, Junji
    Fujiwara, Toshiyoshi
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 39 - 47
  • [2] Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer
    Mariko Kochi
    Takayuki Iwamoto
    Naoki Niikura
    Giampaolo Bianchini
    Shinobu Masuda
    Taeko Mizoo
    Tomohiro Nogami
    Tadahiko Shien
    Takayuki Motoki
    Naruto Taira
    Yutaka Tokuda
    Hiroyoshi Doihara
    Junji Matsuoka
    Toshiyoshi Fujiwara
    Breast Cancer Research and Treatment, 2018, 167 : 39 - 47
  • [3] Tumour-infiltrating lymphocytes (TILs) in breast cancer: A predictive or a prognostic marker?
    Dushyanthen S.
    Savas P.
    Willard-Gallo K.
    Denkert C.
    Salgado R.
    Loi S.
    Current Breast Cancer Reports, 2015, 7 (1) : 59 - 70
  • [4] Tumour-Infiltrating Lymphocytes as a Predictor of Response in Neoadjuvant Endocrine Therapy in Breast Cancer
    Chang, N.
    Hakim, S. W.
    Kos, Z.
    Gravel, D. H.
    Arnaout, A.
    Robertson, S. J.
    MODERN PATHOLOGY, 2014, 27 : 40A - 40A
  • [5] Tumour-Infiltrating Lymphocytes as a Predictor of Response in Neoadjuvant Endocrine Therapy in Breast Cancer
    Chang, N.
    Hakim, S. W.
    Kos, Z.
    Gravel, D. H.
    Arnaout, A.
    Robertson, S. J.
    LABORATORY INVESTIGATION, 2014, 94 : 40A - 40A
  • [6] Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
    Ropponen, KM
    Eskelinen, MJ
    Lipponen, PK
    Alhava, E
    Kosma, VM
    JOURNAL OF PATHOLOGY, 1997, 182 (03): : 318 - 324
  • [7] Tumour-infiltrating lymphocytes (TILs) in patients with epithelial ovarian cancer undergoing neoadjuvant chemotherapy: A retrospective study
    Giovannoni, S.
    Garbi, A.
    Parma, G.
    Lapresa, M.
    Zaccarelli, E.
    Vingiani, A.
    Ardoino, I.
    Pruneri, G.
    Colombo, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 416 - 416
  • [8] Characterisation of Tumour-Infiltrating Lymphocytes in primary breast cancer
    Kyle, F.
    Wu, Y.
    Nussbaumer, O.
    Hessey, S.
    Tutt, A.
    Hayday, A.
    IMMUNOLOGY, 2013, 140 : 19 - 19
  • [9] The value of tumour infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a study in a hospital complex
    Cordoba, A.
    Ruiz de Azua, Y.
    Arean, C.
    Aguiar, B.
    Nova, L.
    Labiano, T.
    Ulazia, A.
    Guerrero, D.
    VIRCHOWS ARCHIV, 2018, 473 : S56 - S56
  • [10] Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy
    Azim, Hatem A., Jr.
    Vingiani, Andrea
    Peccatori, Fedro
    Viale, Giuseppe
    Loi, Sherene
    Pruneri, Giancarlo
    BREAST, 2015, 24 (03): : 290 - 293
12345